Personal CIO

Your investment decisions now start from personal balance sheet, cash flow, current holdings, and risk constraints.

Net Worth

$0.00

17% context

Cash Reserve

$0.00

months unknown

Monthly Surplus

$0.00

$0.00 in / $0.00 out

Investable Cash

$0.00

$0.00 reserve target

Idea Risk

$0.00

50 bps cap

Risk Console

1 signal

Add cash and holdings before accepting any investment idea.

Missing: current holdings or cash balance, cash reserve holding, monthly income, monthly expenses, financial goals and constraints

Holdings

0 lines

Symbol	Asset	Sector	Value	Alloc	P&L
No holdings yet.

Sector Exposure

0.0% max

No sector exposure yet.

Decision Queue

1 pending

Ticker	Status	Risk	Fit Check
META equity / long	ready	49.7 bps	Needs more personal context

Research Inbox

TCEHYcomplete# TCEHY — The Call ## The Call I’m constructive here: TCEHY is a high-quality cash machine trading at a reasonable price, and I think the bull case beats the bear case on the actual numbers. At **58.92**, I do not see a bargain-basement setup, but I do see a business with **30.6% net margin**, **190.17B free cash flow**, **0.54x net debt / EBITDA**, and a valuation of just **15.97x earnings** and

METAcomplete# META — The Call ## The Call I’m bullish here. Not because META is “cheap” in a deep-value sense — it isn’t — but because the market is handing me an elite business at a non-elite multiple while sentiment and the chart are doing the discounting for me. At **$586.14**, I’m looking at **20.96x earnings**, about **17.8x** the **2026 EPS estimate of 32.9583**, and **13.68x EV/EBITDA** for a company p

BABAcomplete# BABA — The Call ## The Call I’m bullish, but not blindly: at **$96.14**, I think BABA is a cheap, controversial value setup, not a high-quality compounder. The stock is being priced as if weak cash conversion and ugly sentiment are permanent, while the balance sheet remains serviceable, profitability is still real, and the valuation has compressed to **14.32x earnings**, **11.43x EV/EBITDA**, **

BABAcomplete# BABA — The Call ## The Call I’m bullish, but only as a contrarian value setup — not as a quality-compounder endorsement. At **$96.14**, I think the market is pricing BABA as if the business is structurally impaired, and that is too harsh given **14.32x P/E**, **1.53x sales**, **11.43x EV/EBITDA**, a still-manageable balance sheet, and a stock already crushed to near its **52-week low of $91.99**

Ask My CIO

Context 17%

Budget Run-Rate

0 items

Type	Label	Amount
No budget items yet.